167 related articles for article (PubMed ID: 33174154)
1. Seizure improvement following vagus nerve stimulator (VNS) battery change with cardiac-based seizure detection automatic stimulation (AutoStim): early experience in a regional paediatric unit.
Lo WB; Chevill B; Philip S; Agrawal S; Walsh AR
Childs Nerv Syst; 2021 Apr; 37(4):1237-1241. PubMed ID: 33174154
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of VNS therapy with AspireSR
Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
[TBL] [Abstract][Full Text] [Related]
3. Autostimulation in Vagus Nerve Stimulator Treatment: Modulating Neuromodulation.
Kulju T; Haapasalo J; Rainesalo S; Lehtimäki K; Peltola J
Neuromodulation; 2019 Jul; 22(5):630-637. PubMed ID: 30549376
[TBL] [Abstract][Full Text] [Related]
4. Evaluating vagus nerve stimulation treatment with heart rate monitoring in pediatric patients with intractable epilepsy.
Santhumayor B; Karkare S; Kothare S; Rodgers S
Childs Nerv Syst; 2022 Mar; 38(3):547-556. PubMed ID: 34837500
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation with tachycardia detection provides additional seizure reduction compared to traditional vagus nerve stimulation.
Datta P; Galla KM; Sajja K; Wichman C; Wang H; Madhavan D
Epilepsy Behav; 2020 Oct; 111():107280. PubMed ID: 32759064
[TBL] [Abstract][Full Text] [Related]
6. Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial.
Fisher RS; Afra P; Macken M; Minecan DN; Bagić A; Benbadis SR; Helmers SL; Sinha SR; Slater J; Treiman D; Begnaud J; Raman P; Najimipour B
Neuromodulation; 2016 Feb; 19(2):188-95. PubMed ID: 26663671
[TBL] [Abstract][Full Text] [Related]
7. Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
Kawaji H; Yamamoto T; Fujimoto A; Uchida D; Ichikawa N; Yamazoe T; Okanishi T; Sato K; Nishimura M; Tanaka T; Namba H
Neurosci Lett; 2020 Jan; 716():134636. PubMed ID: 31751671
[TBL] [Abstract][Full Text] [Related]
8. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation.
Boon P; Vonck K; van Rijckevorsel K; El Tahry R; Elger CE; Mullatti N; Schulze-Bonhage A; Wagner L; Diehl B; Hamer H; Reuber M; Kostov H; Legros B; Noachtar S; Weber YG; Coenen VA; Rooijakkers H; Schijns OE; Selway R; Van Roost D; Eggleston KS; Van Grunderbeek W; Jayewardene AK; McGuire RM
Seizure; 2015 Nov; 32():52-61. PubMed ID: 26552564
[TBL] [Abstract][Full Text] [Related]
9. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
Schneider UC; Bohlmann K; Vajkoczy P; Straub HB
Acta Neurochir (Wien); 2015 Apr; 157(4):721-8. PubMed ID: 25673257
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
[TBL] [Abstract][Full Text] [Related]
11. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy.
Wasade VS; Schultz L; Mohanarangan K; Gaddam A; Schwalb JM; Spanaki-Varelas M
Epilepsy Behav; 2015 Dec; 53():31-6. PubMed ID: 26515157
[TBL] [Abstract][Full Text] [Related]
12. Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study.
Ardesch JJ; Buschman HP; Wagener-Schimmel LJ; van der Aa HE; Hageman G
Seizure; 2007 Oct; 16(7):579-85. PubMed ID: 17543546
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in devices for vagus nerve stimulation.
Mertens A; Raedt R; Gadeyne S; Carrette E; Boon P; Vonck K
Expert Rev Med Devices; 2018 Aug; 15(8):527-539. PubMed ID: 30071175
[TBL] [Abstract][Full Text] [Related]
14. The relationship between duty cycle, tachycardia threshold and autostimulation delivery in cardio-responsive vagus nerve stimulation.
Guzner A; Macken M
Epilepsy Behav; 2021 Mar; 116():107728. PubMed ID: 33486238
[TBL] [Abstract][Full Text] [Related]
15. Investigating the correlation between short-term effectiveness of VNS Therapy in reducing the severity of seizures and long-term responsiveness.
Ravan M
Epilepsy Res; 2017 Jul; 133():46-53. PubMed ID: 28414968
[TBL] [Abstract][Full Text] [Related]
16. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
[TBL] [Abstract][Full Text] [Related]
17. Vagus nerve stimulation: a 20-year Australian experience.
Yates CF; Riney K; Malone S; Shah U; Coulthard LG; Campbell R; Wallace G; Wood M
Acta Neurochir (Wien); 2022 Jan; 164(1):219-227. PubMed ID: 34755209
[TBL] [Abstract][Full Text] [Related]
18. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
Siddiqui F; Herial NA; Ali II
Epilepsy Behav; 2010 Jul; 18(3):299-302. PubMed ID: 20580901
[TBL] [Abstract][Full Text] [Related]
19. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial.
Verrier RL; Nearing BD; Olin B; Boon P; Schachter SC
Epilepsy Behav; 2016 Sep; 62():85-9. PubMed ID: 27450311
[TBL] [Abstract][Full Text] [Related]
20. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
